Expert Opinion on Biological Therapy,
Journal Year:
2022,
Volume and Issue:
22(9), P. 1193 - 1208
Published: Sept. 2, 2022
Ocular
gene
therapy
represents
fertile
ground
for
rapid
innovation,
with
ever-expanding
therapeutic
strategies,
molecular
targets,
and
indications.Potential
indications
ocular
have
classically
focused
on
inherited
retinal
disease
(IRD)
but
more
recently
include
acquired
diseases,
such
as
neovascular
age-related
macular
degeneration,
geographic
atrophy,
diabetic
retinopathy.
strategies
proliferated
recently,
augmentation,
inactivation,
editing,
RNA
modulation,
gene-independent
augmentation.
Viral
vector
constructs
adeno-associated
virus
lentivirus
continue
to
evolve
through
directed
evolution
rationale
design.
administration
techniques
expanded
beyond
pars
plana
vitrectomy
subretinal
injection
intravitreal
suprachoroidal
injection.The
success
of
treatment
IRD,
paired
the
promise
clinical
research
in
diseases
techniques,
has
raised
possibility
in-office
common
disorders
within
next
5
10
years.
Frontiers in Medicine,
Journal Year:
2023,
Volume and Issue:
10
Published: June 20, 2023
Keratoconus
is
the
most
common
corneal
ectatic
disorder.
It
characterized
by
progressive
thinning
with
resultant
irregular
astigmatism
and
myopia.
Its
prevalence
has
been
estimated
at
1:375
to
1:2,000
people
globally,
a
considerably
higher
rate
in
younger
populations.
Over
past
two
decades,
there
was
paradigm
shift
management
of
keratoconus.
The
treatment
expanded
significantly
from
conservative
(e.g.,
spectacles
contact
lenses
wear)
penetrating
keratoplasty
many
other
therapeutic
refractive
modalities,
including
cross-linking
(with
various
protocols/techniques),
combined
CXL-keratorefractive
surgeries,
intracorneal
ring
segments,
anterior
lamellar
keratoplasty,
more
recently,
Bowman's
layer
transplantation,
stromal
keratophakia,
regeneration.
Several
recent
large
genome-wide
association
studies
(GWAS)
have
identified
important
genetic
mutations
relevant
keratoconus,
facilitating
development
potential
gene
therapy
targeting
keratoconus
halting
disease
progression.
In
addition,
attempts
made
leverage
power
artificial
intelligence-assisted
algorithms
enabling
earlier
detection
progression
prediction
this
review,
we
provide
comprehensive
overview
current
emerging
propose
algorithm
for
systematically
guiding
clinical
entity.
Frontiers in Molecular Neuroscience,
Journal Year:
2023,
Volume and Issue:
15
Published: Jan. 9, 2023
Inherited
retinal
diseases
(IRDs)
are
associated
with
mutations
in
over
250
genes
and
represent
a
major
cause
of
irreversible
blindness
worldwide.
While
gene
augmentation
or
editing
therapies
could
address
the
underlying
genetic
small
subset
patients,
their
utility
remains
limited
by
great
heterogeneity
IRDs
costs
developing
individualised
therapies.
Gene-agnostic
therapeutic
approaches
target
common
pathogenic
pathways
that
drive
degeneration
provide
functional
rescue
vision
independent
cause,
thus
offering
potential
clinical
benefits
to
all
IRD
patients.
Here,
we
review
key
gene-agnostic
approaches,
including
cell
reprogramming
replacement,
neurotrophic
support,
immune
modulation
optogenetics.
The
relative
limitations
these
strategies
timing
interventions
discussed.
Investigative Ophthalmology & Visual Science,
Journal Year:
2024,
Volume and Issue:
65(6), P. 5 - 5
Published: June 4, 2024
Purpose:
The
purpose
of
this
study
was
to
evaluate
self-reported
functional
vision
(FV)
and
the
impact
loss
in
patients
with
USH2A-associated
retinal
degeneration
using
a
patient-reported
outcome
(PRO)
measure,
Michigan
Retinal
Degeneration
Questionnaire
(MRDQ),
correlate
MRDQ
scores
well-established
visual
function
measurements.
Design:
An
observational
cross-sectional
(n
=
93)
participants
who
had
Usher
Syndrome
Type
2
(USH2,
n
55)
or
autosomal
recessive
non-syndromic
retinitis
pigmentosa
(ARRP;
38)
associated
biallelic
variants
USH2A
gene.
Methods:
protocol
approved
by
all
ethics
boards
informed
consent
obtained
from
each
participant.
Participants
completed
at
48-month
follow-up
visit.
Disease
duration
participants.
One-way
ANOVA
used
compare
subgroups
(clinical
diagnosis,
age,
disease
duration,
full-field
stimulus
threshold
[FST]
Blue-Red
mediation)
on
mean
per
domain.
Spearman
correlation
coefficients
were
assess
associations
between
domains
visual/retinal
assessments.
Results:
Of
sample,
58%
female
median
13
years.
sensitive
differences
clinical
FST
mediation.
correlated
static
perimetry,
microperimetry,
testing,
best-corrected
acuity
(BCVA).
Conclusions:
Self-reported
FV
measured
MRDQ,
when
applied
USH2
ARRP
participants,
good
distributional
characteristics
well
tests.
adds
new
dimension
understanding
vision-related
functioning
establishes
PRO
tool
as
an
informative
measure
evaluating
outcomes.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(18), P. 5512 - 5512
Published: Sept. 18, 2024
Inherited
retinal
diseases
(IRDs)
encompass
a
wide
spectrum
of
rare
conditions
characterized
by
diverse
phenotypes
associated
with
hundreds
genetic
variations,
often
leading
to
progressive
visual
impairment
and
profound
vision
loss.
Multiple
natural
history
studies
clinical
trials
exploring
gene
therapy
for
various
IRDs
are
ongoing.
Outcomes
ophthalmic
measure
changes
in
three
main
categories-structural,
functional,
patient-focused
outcomes.
Since
may
range
from
congenital
poor
central
birth
affecting
the
peripheral
retina
initially
progressing
insidiously
acuity
affected
late
disease
course,
typical
outcome
measures
such
as
ocular
coherence
tomography
(OCT)
imaging
macula
not
provide
adequate
representation
therapeutic
outcomes
including
alterations
course.
Thus,
alternative
unique
necessary
assess
loss
vision,
color
night
contrast
sensitivity
IRDs.
These
differences
have
complicated
assessment
IRD
therapies,
had
design
novel
specialized
endpoints
demonstrate
treatment
efficacy.
As
engineering
techniques
continue
advance
growing
investment
industry
accelerated
approval
tracks
orphan
conditions,
must
improve
their
assessments
safety
efficacy
new
therapies
that
aim
come
market.
Here,
we
will
an
overview
current
approaches,
review
measuring
function,
highlight
those
utilized
recent
trials,
stage
2
3
through
second
quarter
2024.
Translational Vision Science & Technology,
Journal Year:
2024,
Volume and Issue:
13(7), P. 7 - 7
Published: July 9, 2024
Purpose:
Lipid
nanoparticles
(LNPs)
show
promise
in
their
ability
to
introduce
mRNA
drive
protein
expression
specific
cell
types
of
the
mammalian
eye.
Here,
we
examined
encapsulated
LNPs
with
two
distinct
formulations
gene
mouse
and
human
retina
other
ocular
tissues.
Methods:
We
introduced
mRNA-carrying
into
biological
systems.
Intravitreal
injections
were
tested
deliver
Human
retinal
pigment
epithelium
(RPE)
explants
used
assess
tissue.
analyzed
specificity
using
histology,
immunofluorescence,
imaging.
Results:
In
mice,
mRNAs
encoding
GFP
ciliary
neurotrophic
factor
(CNTF)
specifically
expressed
by
Müller
glia
RPE.
Acute
inflammatory
changes
measured
microglia
distribution
(Iba-1)
or
interleukin-6
(IL-6)
not
observed
6
hours
post-injection.
RPE
also
high
levels
GFP.
cells
apical
basal
processes
consistent
perivascular
macrophages.
Conclusions:
demonstrated
reliably
transfect
subpopulations
eye
tissues
vivo
Of
significance,
intravitreal
sufficient
mice.
To
our
knowledge,
demonstrate
delivery
for
first
time.
Translational
Relevance:
Ocular
gene-replacement
therapies
non-viral
vector
methods
are
a
promising
alternative
adeno-associated
virus
(AAV)
vectors.
Our
studies
that
LNP
can
be
both
without
inducing
significant
inflammation.
This
methodology
could
lines,
tissue
explants,
potentially
as
therapy
clinical
setting
future.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(33)
Published: Oct. 17, 2022
Abstract
Nanoneedles
can
target
nucleic
acid
transfection
to
primary
cells
at
tissue
interfaces
with
high
efficiency
and
minimal
perturbation.
The
corneal
endothelium
is
an
ideal
for
nanoneedle‐mediated
RNA
interference
therapy
aimed
enhancing
its
proliferative
capacity,
necessary
regeneration.
This
work
develops
a
strategy
siRNA
nanoninjection
the
human
endothelium.
deliver
p16‐targeting
endothelial
in
vitro
without
toxicity.
nanoinjection
of
induces
p16
silencing
increases
cell
proliferation,
as
monitored
by
ki67
expression.
Furthermore,
targeting
nontoxic
ex
vivo,
silences
transfected
cells.
These
data
indicate
that
support
targeted
treatment
dysfunction.
Kidney International,
Journal Year:
2023,
Volume and Issue:
104(2), P. 245 - 253
Published: May 25, 2023
Nephronophthisis
is
an
autosomal
recessive
tubulointerstitial
nephropathy,
belonging
to
the
ciliopathy
disorders,
characterized
by
fibrosis
and/or
cysts.
It
most
common
genetic
cause
of
kidney
failure
in
children
and
young
adults.
Clinically
genetically
heterogeneous,
it
caused
variants
ciliary
genes,
resulting
either
isolated
disease
or
syndromic
forms
association
with
other
manifestations
disorders.
No
curative
treatment
currently
available.
Over
past
2
decades,
advances
understanding
mechanisms
have
identified
several
dysregulated
signaling
pathways,
some
shared
cystic
diseases.
Notably,
molecules
previously
developed
target
these
pathways
shown
promising
beneficial
effects
orthologous
mouse
models.
In
addition
knowledge-based
repurposing
approaches,
unbiased
"in
cellulo"
phenotypic
screens
"repurposing"
libraries
small
able
rescue
ciliogenesis
defects
observed
nephronophthisis
conditions.
Those
compounds
appeared
act
on
relevant
and,
when
tested,
showed
nephronophthisis-associated
extrarenal
mice.
this
review,
we
summarized
those
studies
that
highlight
drug
strategies
context
a
rare
such
as
nephronophthisis-related
ciliopathies,
broad
heterogeneity
systemic
but
mechanisms.
Translational Vision Science & Technology,
Journal Year:
2025,
Volume and Issue:
14(2), P. 16 - 16
Published: Feb. 11, 2025
Purpose:
This
study
compares
clinical
characteristics
of
retinitis
pigmentosa
(RP)
associated
with
mutations
in
the
EYS
and
USH2A
genes
a
Southeast
Asian
cohort.
Methods:
Prospective
single-center
families
EYS-
or
USH2A-associated
RP
seen
at
Singapore
National
Eye
Centre.
Comprehensive
ophthalmic
evaluations,
multimodal
imaging,
genetic
testing,
longitudinal
follow-up
identified
clinically
useful
differentiating
features
between
two
genotypes.
Results:
A
total
300
were
enrolled,
RP,
accounting
for
24.7%
all
probands
50.7%
solved
likely
cases.
cases
predominantly
nonsyndromic
(75%).
EYS-associated
was
more
severe
functional
structural
outcomes,
patients
myopic
than
(SE
−3.31
vs.
−0.69;
P
<
0.0001).
displayed
peripapillary
nasal
sparing
on
autofluorescence
imaging
frequently
(57.6%
26.7%;
=
0.006),
whereas
often
had
parafoveal
ring
(73.3%
30.3%;
0.0002).
Multiple
logistic
regression
diagnostic
83.2%
accuracy
distinguishing
USH2A,
validated
second
unrelated
Conclusions:
have
overlapping
presentations
but
can
be
distinguished
based
constellation
phenotypic
including
disease
onset
severity,
refractive
error,
fundus
autofluorescence.
These
may
support
effective
strategy
these
common
forms
RP.
Translational
Relevance:
Distinct
provide
valuable
tools
that
inform
personalized
management
facilitate
targeted
interventions
practice.